Reference - Detail
| RRC ID | 58089 |
|---|---|
| Author | Hiyoshi Y, Sato Y, Ichinoe M, Nagashio R, Hagiuda D, Kobayashi M, Kusuhara S, Igawa S, Shiomi K, Goshima N, Murakumo Y, Saegusa M, Satoh Y, Masuda N, Naoki K. |
| Title | Prognostic significance of IMMT expression in surgically-resected lung adenocarcinoma. |
| Journal | Thorac Cancer |
| Abstract |
BACKGROUND:Mitochondrial dysfunction contributes to many types of human disorders and cancer progression. Inner membrane mitochondrial protein (IMMT) plays an important role in the maintenance of mitochondrial structure and function. The aims of this study were to examine IMMT expression in lung adenocarcinoma and evaluate its correlation with clinicopathological parameters and patient prognosis. METHODS:IMMT expression was immunohistochemically studied in 176 consecutive lung adenocarcinoma resection tissues, and its correlations with clinicopathological parameters were evaluated. Kaplan-Meier survival analysis and Cox-proportional hazards models were used to estimate the effect of IMMT expression on survival. RESULTS:High-IMMT expression was detected in 84 of 176 (47.7%) lung adenocarcinomas. Levels were significantly correlated with advanced disease stage (stage II and III; P = 0.024), larger tumor size (>3 cm; P = 0.002), intratumoral vascular invasion (P < 0.001), and poorer adenocarcinoma patient prognosis (P = 0.002). Based on 176 patients with adenocarcinoma, multivariate analysis revealed that IMMT expression was an independent predictor of poorer survival (HR, 1.99; 95% confidence interval [CI], 1.06-3.74; P = 0.031). Further, treating A549 cells derived from lung adenocarcinoma, with IMMT siRNA resulted in significantly decreased proliferation. CONCLUSION:Here, we first demonstrated that high-IMMT expression is related to some clinicopathological parameters, and that its expression is an independent prognostic predictor of poorer survival in patients with lung adenocarcinoma; further studies are required to clarify the biological function of IMMT in lung adenocarcinoma. However, results suggest that this protein could be a novel prognostic indicator and therapeutic target. |
| Volume | 10(11) |
| Pages | 2142-2151 |
| Published | 2019-11-1 |
| DOI | 10.1111/1759-7714.13200 |
| PMID | 31583841 |
| PMC | PMC6825906 |
| MeSH | Adenocarcinoma of Lung / metabolism Adenocarcinoma of Lung / pathology Adenocarcinoma of Lung / surgery* Biomarkers, Tumor / metabolism Female Gene Expression Regulation, Neoplastic Humans Lung Neoplasms / metabolism Lung Neoplasms / pathology Lung Neoplasms / surgery* Male Mitochondrial Proteins / metabolism* Muscle Proteins / metabolism* Neoplasm Staging Prognosis Survival Analysis Up-Regulation* |
| IF | 2.524 |
| Times Cited | 1 |
| Resource | |
| Human and Animal Cells | LC-2/ad(RCB0440) SP2/0-Ag14(RCB0209) |